Starbucks Corp (SBUX) is a coffeehouse chain and is categorized in the restaurant industry. They provide their customers with selected sorts of coffee from all over the world, as well as tea, cold beverages, patisserie, hot and cold food offers. Their competitors consist of local coffee shops as
On Friday, our Under the Radar Moversnewsletter suggestedsmall cap precision and specialty motion control stock Allied Motion Technologies (NASDAQ: AMOT) as a possible long position:
Finally, we mulled going ahead and getting into another longer-term position today, but managed to talk ourselves out of it… for the time being anyway. We do intend to get into it soon though, when the....More>>>
When it comes to safe stocks, there may be none safer than healthcare conglomerate Johnson & Johnson (NYSE:JNJ). Johnson & Johnson is often a staple holding for income seekers, conservative investors, and even value investors. It has a 54-year streak of increasing its dividend payout, which should almost certainly become 55 years come April, and it’s one of two remaining publicly listed....More>>>
Welcome to the latest issue of the PRO Weekly Digest. Every Saturday for Seeking Alpha PRO subscribers and Sunday for all other Seeking Alpha users, we publish highlights from our PRO coverage as well as feature interviews and other notable goings-on with SA PRO. Comment below or email us at pro-editors at seekingalpha.com to let us know what you think. Find past editions here.
Shares of casino operators have been on the rise after news broke that monthly gaming revenue in Macau increased for the first time since May of 2014, likely driven mostly by new openings. The news sent shares of Las Vegas Sands (NYSE:LVS) up 7.4%, shares of Melco Crown Entertainment (NASDAQ:MPEL) up 8.7%, shares of Wynn Resorts (NASDAQ:WYNN) up 3.4%, and shares of MGM Resorts (NYSE:MGM) up 2.9%....More>>>
The debt ceiling deadline is Wednesday, March 15, 2017, and the reinstatement of the debt ceiling could spell disaster for the current bull market. Fortunately, we’ve created an investment plan to weather any market volatility that comes after the debt ceiling deadline (which we’ll get to in just a moment).
The debt ceiling was temporarily eliminated in October 2015 to prevent....More>>>
Welcome to another installment of “3 Things in Biotech You Should Learn Today.” In this episode, we’re going to consider the news of a few “out there” technologies, namely CRISPR gene editing and tumor-treating fields. Then, we’ll come back to something a little closer to conventional.
Wall Street analysts tend to be a bullish lot, and few have been as bullish as FundStrat’s Thomas Lee, who’s been accused of being a perma-bull. But just as his colleagues seem to be embracing another year of gains, Lee has decided to dial back the optimism. In his 2017 outlook released today, Lee wrote that he expects that S&P 500 to finish the year at 2,275, down a few points from....More>>>
You wouldn’t know it from the headlines about obesity, but Americans spend a lot of time and money on fitness — and that spending is rising every year. The aging of America, which eventually could be a drag on the fitness segment as the Baby Boom population gets extremely old, is still a net positive: doctors increasingly insist that seniors stay active, driving demand for athletic shoes....More>>>
If youre among the one in five Americans making a lifestyle choice to avoid gluten — a protein found in wheat, rye, and barley — or the one in 100 Americans diagnosed with celiac disease, which prohibits gluten intake, youve likely seen your food costs go up.
SEE ALSO: The Most-Overlooked Tax Deductions
Restaurants often charge more for gluten-free pizza crust or pasta,....More>>>
I have written about Global Blood Therapeutics (NASDAQ:GBT) before here. In my prior article, I addressed a number of fairly legitimate concerns people have cited about the stock and its lead drug for sickle cell disease (“SCD”) called GBT-440, and I explained how those risks are less significant than one might believe, or are being successfully mitigated by the company.
Sprint (NYSE:S) remains one of my more compelling ideas in the telecom space, as I’m anticipating that it can address network speeds at far greater levels of capital efficiency than what I had originally anticipated. Furthermore, the fundamental value equation still seems intact, as there’s meaningful potential to improving profitability despite lower than average ARPU per postpaid subscriber....More>>>
Remember that moment in Eddie Murphy’s Coming to America where Randolph and Mortimer Duke are handed a bag of money, giving them a chance to rebuild the wealth they lost in Trading Places? When it happens, Randolph turns to Mortimer and simply says…”We’re back”
Michael Nagle/Bloomberg News
We know how they feel. After one of the worst starts to....More>>>
Shares of Sarepta Therapeutics (SRPT) have gotten crushed today after the FDA offered a negative take on Sarepta’s Duchenne muscular dystrophy drug. In fact, Leerink’s Joseph Schwartz and team contend that Sarepta’s “dystrophin argument strongly challenged and largely invalidated by the FDA.” They explain:
The global chemical industry has gotten off to a positive start in the fourth quarter with October seeing a rise in chemical production on the back of a recovery of the U.S. chemical industry from the effects of hurricanes and an upswing in the world economy, per the monthly report from the Amer
MannKind (MNKD) investors have seen scripts rising modestly over the course of Q4. Modest sales growth has been a common theme with Afrezza that everyone is pretty much used to at this point. Perhaps more interesting is the trajectory of retail sales revenue we are seeing.